T-wave oversensing in implantable cardiac defibrillators is due to technical failure of device sensing

Journal of Cardiovascular Electrophysiology

Volumn 17, Issue 5, 2006, Pages 553-556

  Gilliam III, F Roosevelt ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Implantable cardioverter defibrillator; Inappropriate shocks; T wave oversensing

Indexed keywords

ADULT; CASE REPORT; DEFIBRILLATOR; DEVICE; GENERATOR; HEART DEATH; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; INCIDENCE; MALE; PRIORITY JOURNAL; REVIEW; SIGNAL PROCESSING; T WAVE; TREATMENT INDICATION;

DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; EQUIPMENT FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR;

EID: 33645964655     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2005.00350.x     Document Type: Review

References (13)

1. Weretka S Michaelsen J Becker R et al Ventricular oversensing: A study of 101 patients implanted with dual chamber defibrillators and two different lead systems. Pacing Clin Electrophysiol 2003 26 pt 1 65 70.
2. Washizuka T Chinushi M Tagawa M et al Inappropriate discharges by fourth generation implantable cardioverter defibrillators in patients with ventricular arrhythmias. Jpn Circ J 2001 65 927 930.
3. Perry GY Kosar EM Problems in managing patients with long QT syndrome and implantable cardioverter defibrillators: A report of two cases. Pacing Clin Electrophysiol 1996 19 863 867.
4. Schimpf R Wolpert C Bianchi F et al Congenital short QT syndrome and implantable cardioverter defibrillator treatment: Inherent risk for inappropriate shock delivery. J Cardiovasc Electrophysiol 2003 14 1273 1277.
5. Jesel L Morel O Levy J et al Endocardial signal highlights potential T-wave oversensing in Brugada patients with ICD abstract Heart Rhythm 2004 1 S244.
6. Koul AK Keller S Clancy JF et al Hyperkalemia induced T-wave oversensing leading to loss of biventricular pacing and inappropriate ICD shocks. Pacing Clin Electrophysiol 2004 27 681 683.
7. Moss AJ Zareba W Hall WJ et al Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. multicenter automatic defibrillator implantation trial II investigators. N Engl J Med 2002 346 877 883.
8. Bardy GH Lee KL Mark DB Poole JE Packer DL Boineau R Domanski M Troutman C Anderson J Johnson G McNulty SE Clapp-Channing N Davidson-Ray LD Fraulo ES Fishbein DP Luceri RM Ip JH the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 225 237.
9. Bristow MR Saxon LA Boehmer J et al Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. For the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. N Engl J Med 2004 350 2140 2150.
10. Russo AM Nayak H Verdino R et al Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: Is device implantation justified? Pacing Clin Electrophysiol 2003 26 2289 2295.
11. Theuns D Klootwijk AP Kimman GP et al Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators. Europace 2001 3 181 186.
12. Stix G Bella PD Carbucicchio C et al Spatial and temporal heterogeneity of depolarization and repolarization may complicate implantable cardioverter defibrillator therapy in Brugada syndrome. J Cardiovasc Electrophysiol 2000 11 516 521.
13. Degeratu FT Khalighi K Peters RW et al Sensing lead failure in implantable defibrillators: A comparison of two commonly used leads. J Cardiovasc Electrophysiol 2000 11 21 24.